本页面由Tiger Trade Technology Pte. Ltd.提供服务

InMed Pharmaceuticals Inc

1.33
-0.0300-2.21%
盘后:1.330.00000.00%19:30 EDT
成交量:2.82万
成交额:3.75万
市值:730.67万
市盈率:-0.43
高:1.37
开:1.34
低:1.33
收:1.36
52周最高:2.33
52周最低:0.5750
股本:549.37万
流通股本:214.99万
量比:0.93
换手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-3.1200
每股收益(LYR):-8.3630
净资产收益率:-156.77%
总资产收益率:-66.46%
市净率:6.80
市盈率(LYR):-0.16

数据加载中...

2026/10/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/18

重要事件披露

Form 8-K - Current report
2026/09/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/09/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/22

重要事件披露

Form 8-K - Current report
2026/07/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/05

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/27

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/19

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/27

重要事件披露

Form 8-K - Current report